Pulse nav.journalClub Tendances Explorer Chercheurs

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Politique de confidentialité

Accueil Explorer nav.journalClub Tendances

⌘+K

CJC-1295 — Research & Evidence | Synapse

Topics/CJC-1295

Cardiology

CJC-1295

Studies on CJC-1295, a long-acting GHRH analog, in growth hormone axis and body-composition research contexts.

Unknown pathwayAlso known as: CJC-1295, CJC1295, growth hormone releasing hormone analog

0

Claims analyzed

Consensus Evidence brief

What does the research say about CJC-1295?

Unknown pathwayBased on 0 claims ( agreements, contradictions)

Topic has no MeSH concept mappings

Evidence brief: CJC-1295

CJC-1295 (also known as CJC-1295, CJC1295, growth hormone releasing hormone analog). Studies on CJC-1295, a long-acting GHRH analog, in growth hormone axis and body-composition research contexts.

As of 2026-06-24, the scientific consensus on CJC-1295 is unknown. Topic has no MeSH concept mappings

This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/6a20b94d2eacf7592fbe2c15.

Deterministic synthesis from Synapse's enriched corpus — 53 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.

Follow the latest CJC-1295 research

Explore every CJC-1295 paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.

Search CJC-1295 papers

Powered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers